© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 12, 2017
Readmission reduction has the potential for broad impact, especially in disadvantaged populations.
Lawrence Eichenfield, MD: Phase 3 Trial Data on Ruxolitinib for Atopic Dermatitis
Karan Lal, DO: Relationship Between Psoriasis and the Skin, Gut Microbiome
Karan Lal, DO: Psoriasis Treatment Advances, Spesolimab for Generalized Pustular Psoriasis